The board expanded the total number of shares authorized for repurchase to 6.5 million shares from 6.2 million shares.
Under the repurchase program, a total of 288,158 shares remained authorized for repurchase.
Price: 10.29, Change: 0.00, Percent Change: 0.00
|MT Newswires After Hours Watch List: ABCL, FANG, GRTS|
|Kymera Therapeutics Chief Scientific Officer Cheswor...|
|Update: AbCellera Jumps 20% After Hours as FDA Expan...|
|Insider Buy: Oscar Health|
|Insider Sell: Outset Medical|